We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12.3B
AUM Growth
+$1.06B
Cap. Flow
+$761M
Cap. Flow %
6.18%
Top 10 Hldgs %
58.32%
Holding
100
New
18
Increased
36
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$896M
2
COL
Rockwell Collins
COL
+$339M
3
MON
Monsanto Co
MON
+$161M
4
ELV icon
Elevance Health
ELV
+$131M
5
CHTR icon
Charter Communications
CHTR
+$92.5M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$508M
2
TWX
Time Warner Inc
TWX
+$393M
3
HDS
HD Supply Holdings, Inc.
HDS
+$196M
4
KITE
Kite Pharma, Inc.
KITE
+$175M
5
ALR
Alere Inc
ALR
+$138M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 13.94%
3 Communication Services 13.94%
4 Financials 11.79%
5 Industrials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
76
KALA BIO
KALA
$14.1M
$3.42M 0.03%
74
+34
+85% +$1.59M
SNI
77
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$3.42M 0.03%
40,000
-195,000
-83% -$16.1M
BKD icon
78
Brookdale Senior Living
BKD
$3.49B
$3.2M 0.03%
330,000
– –
BMS
79
DELISTED
Bemis
BMS
$2.87M 0.02%
+60,000
New +$2.77M
GCVRZ
80
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.6M 0.02%
6,827,805
– –
CYOU
81
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$2.55M 0.02%
70,000
-170,000
-71% -$6.42M
CLLS
82
Cellectis
CLLS
$277M
– –
-385,000
Closed -$11M
CMCSA icon
83
Comcast
CMCSA
$85B
– –
-1,741,621
Closed -$67M
EXEL icon
84
Exelixis
EXEL
$13.3B
– –
-1,190,000
Closed -$28.8M
GILD icon
85
Gilead Sciences
GILD
$162B
– –
-945,000
Closed -$76.6M
HLF icon
86
Herbalife
HLF
$1.29B
– –
-2,519,670
Closed -$85.5M
RGNX icon
87
Regenxbio
RGNX
$620M
– –
-417,000
Closed -$13.7M
RYAAY icon
88
Ryanair
RYAAY
$30.4B
– –
-488,455
Closed -$20.6M
SBAC icon
89
SBA Communications
SBAC
$19.2B
– –
-136,738
Closed -$19.7M
STZ icon
90
Constellation Brands
STZ
$22.2B
– –
-654,869
Closed -$131M
DCPH
91
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-100,000
Closed -$1.9M
HDS
92
DELISTED
HD Supply Holdings, Inc.
HDS
– –
-5,434,168
Closed -$196M
STML
93
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-1,187,500
Closed -$13.2M
NITE
94
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
– –
-40,300
Closed -$774K
BRCD
95
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
– –
-5,130,000
Closed -$61.3M
KITE
96
DELISTED
Kite Pharma, Inc.
KITE
– –
-974,435
Closed -$175M
ALR
97
DELISTED
Alere Inc
ALR
– –
-2,700,000
Closed -$138M
PCO
98
DELISTED
Pendrell Corporation - Class A
PCO
– –
-8,211
Closed -$5.61M
ESV
99
DELISTED
Ensco Rowan plc
ESV
– –
-1,230,000
Closed -$29.4M
BCR
100
DELISTED
CR Bard Inc.
BCR
– –
-1,585,000
Closed -$508M
1 2 3
4

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Farallon Capital Management held 100 positions worth $12.3B, up 9.4% from $11.3B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Farallon Capital Management deployed $761M of net new capital in Q4 2017, opening 18 new positions and adding to 36 existing holdings. Its largest new stake was Aetna Inc: 5,215,000 shares worth $941M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Time Warner Inc, an estimated $393M trimmed.

  • Farallon Capital Management's largest Q4 2017 buy was Aetna Inc: 5,215,000 shares worth $941M.
  • Farallon Capital Management added most to Monsanto Co in Q4 2017, an estimated $161M increase.
  • Farallon Capital Management's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $393M.
  • Farallon Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $508M.
  • Farallon Capital Management's ten largest holdings make up 58% of its $12.3B portfolio in Q4 2017.
  • Farallon Capital Management opened 18 new positions and closed 19 in Q4 2017.
  • Farallon Capital Management's portfolio value rose 9.4% quarter-over-quarter to $12.3B.

Based on Farallon Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.